Oncology
2 drugs are in development for Ovary Cancer.
- Companies
- 2
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Ovary Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| STRO-002 | SUTRO BIOPHARMA, INC. (STRO) |
Phase 1(1)
| Drug | Company |
|---|---|
| NUV-868 | Nuvation Bio Inc. (NUVB) |
About this indication
Ovary Cancer context
Oncology·MeSH: Ovarian Neoplasms (D010051)
Narrower concept of MeSH descriptor Ovarian Neoplasms
Compare drugs
Frequently asked questions
How many drugs are in development for Ovary Cancer?
BioSniper tracks 2 drugs in development for Ovary Cancer across 2 companies.
How many clinical trials target Ovary Cancer?
There are 6 clinical trials targeting Ovary Cancer tracked by BioSniper.